Product Information

DILTIAZEM 12HR ER 90 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $1.7499 per EA under NDC 24979018201. Its NADAC has been published 146 times since Jan 31, 2024.

FDA first approved this application on Mar 1, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 12HR ER 90 MG CAP

diltiazem hydrochloride
$1.7499per EA

Strength

90 mg/1

NDC

24979018201

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217377

FDA Approved

3/1/2023

TE Code

AB1

On Market Since

5/1/2023

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 12HR ER 90 MG CAP has been published 146 times since Jan 31, 2024, and over the history we have for it it has declined 37.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7499 per EA
All-time high$2.8067 (Apr 10, 2024)
All-time low$1.6614 (Sep 23, 2026)
52-week high$1.8385
52-week low$1.6614
Median price$1.8950
Average price$2.0127
Largest weekly change-15.6% (Apr 17, 2024)
Weeks tracked146
Tracking sinceJan 31, 2024

Price History

1W

0.0%

1M

+5.3%

3M

-2.7%

6M

+2.8%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

-37.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DILTIAZEM 12HR ER 90 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 90 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $1.7499 per EA (NDC 24979018201), effective Nov 11, 2026.

How has the price of DILTIAZEM 12HR ER 90 MG CAP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 90 MG CAP has declined 37.7%. It has been tracked across 146 weekly CMS publications since Jan 31, 2024.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 90 MG CAP?

Since Jan 31, 2024, the NADAC for DILTIAZEM 12HR ER 90 MG CAP has ranged from a low of $1.6614 (Sep 23, 2026) to a high of $2.8067 (Apr 10, 2024), with a median of $1.8950 per EA.

Are there cheaper alternatives to DILTIAZEM 12HR ER 90 MG CAP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 12HR ER 90 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 12HR ER 90 MG CAP?

DILTIAZEM 12HR ER 90 MG CAP (NDC 24979018201) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.